Type II iodothyronine deiodinase is a short-lived, membranebound enzyme found in rat brain, brown adipose tissue, and cAMPstimulated astrocytes. Recently, a full-length complementary DNA (cDNA) encoding a 30-kDa, type II-like selenodeiodinase was cloned from frog, and a homologous partial cDNA (rBAT 1.1), containing two in-frame selenocysteine codons (UGA), was isolated from rat brown adipose tissue. Importantly, the rBAT 1.1 cDNA was derived from a 7.5-kb messenger RNA (mRNA) and did not encode a functional selenoenzyne unless an enabling selenocysteine insertion sequence was appended to the presumed coding region and this cDNA. In this study we determined whether the native 7.5-kb SeD2 mRNA in rat tissues programmed the synthesis of the native type II deiodinase using specific antibodies that were raised against the C-terminus of fulllength, 30-kDa SeD2 protein and against the catalytic core of SeD2.
T YPE II iodothyronine 5Ј-deiodinase (D2) catalyzes the deiodination of T 4 to its active metabolite, T 3 , and generates most of the T 3 found in brain, pituitary, and brown adipose tissue (BAT) (1) (2) (3) . D2 differs from the more abundant type I iodothyronine deiodinase (D1) in physiochemical properties (4) and substrate preference, and is not inhibited by 6-n-propyl-2-thiouracil (PTU) (5) . D2 is also distinguished from the other deiodinases by the rapid, T 4 -dependent modulation of brain D2 levels (6 -11) and the lack of effect of Se deprivation on D2 activity or its 29-kDa substrate-binding subunit (12) . On the other hand, both D1 and the tyrosyl ring deiodinase, D3, are approximately 30-kDa selenoproteins (13) (14) (15) (16) (17) , and catalytic potential is directly related to the cellular Se concentration (18 -21) .
The 29-kDa substrate-binding subunit, p29, is the best characterized subunit of mammalian D2. This subunit was identified by affinity-labeling techniques (4, 22) and was characterized by showing that the rate of bromoacetyl-T 4 (BrAcT 4 ) label incorporation equaled the rate of BrAcT 4 -dependent inhibition of D2 activity, and that the quantity of affinity-labeled p29 paralleled D2 activity levels under conditions of enzyme over-and underexpression (22) . Competition studies revealed that substrates, but not products, selectively blocked the affinity labeling of p29 and preserved D2 activity (22) . Gel filtration of the detergent-soluble enzyme showed that D2 had a M r of approximately 200,000 (4, 23) and was composed of one or more p29 subunits, an approximately 60-kDa cAMP-induced activation protein (CAP) (23) , and one or more catalytic subunits.
One major difference between D2 and the other selenodeiodinases (D1 and D3) is the failure of Se deficiency to eliminate catalytic activity (12, 24, 25) . In Se-depleted astrocytes, steady state levels of D2 activity are modestly, if at all, affected, and the synthesis of its p29 subunit is not altered (12) , even though two other selenoenzymes, glutathione peroxidase (GPx) and D3, are almost completely lost (12, 15) . Similarly, in vivo, cerebrocortical D2 activity is unaffected by Se deficiency, whereas brain GPx levels show the expected fall (24) . Differential preservation of the different classes of selenoproteins has been proposed to account for the lack of effect of Se on D2 activity during periods of Se deprivation; however, the short biological half-life (t 1/2 , Ͻ20 min) of D2 and its low abundance in the cell make this protein especially susceptible to an impaired translational machinery. In fact, direct analysis of expressed selenoproteins in astrocytes failed to identify any 30-kDa translation product(s), suggesting that D2 is not Se dependent and that the p29 subunit of D2 is not a selenoprotein (12) .
Despite characterization of the biology and biochemistry of D2 and its p29 subunit, a selenoprotein with the some of the catalytic properties of D2 from frog skin was recently cloned (26) . Homology cloning led to the discovery of a similar gene product in rat BAT and human brain (27) , challenging the widely held view that D2 was not a selenodeiodinase. Unlike mammals, frogs lack D1 and rely on a D2-like enzyme to catalyze T 3 production during metamorphosis (28) . Galton and co-workers isolated a full-length, frog type II selenodeiodinase complementary DNA (cDNA), SeD2, containing both the selenocysteine (SeC) codon (UGA) and the obligatory selenocysteine insertion sequence (SECIS) located in the 3Ј-untranslated region (3ЈUTR) (26) . In all eukaryotic transcripts, the UGA triplet functions as a stop codon unless it is reinterpreted to code for SeC insertion by a specific stem loop element (SECIS) located in the 3ЈUTR (29) . Transient expression of the frog SeD2 cDNA in COS cells produced a deiodinase that catalyzed the PTU-resistant 5Ј-deiodination of T 4 (26) , consistent with the D2 operational classification (1) (2) (3) .
A homologous, partial gene product (ϳ1.5-kb cDNA) was isolated from a cold stimulated rat BAT cDNA library that coded for a putative 30-kDa selenoprotein with approximately 80% amino acid identity to that of frog SeD2 (27) . However, attempts to express a functional enzyme failed (27) , presumably due to the lack of the SECIS in the BAT SeD2 cDNA. As we showed that attaching a SECIS to the 3ЈUTR of any eukaryotic transcript containing a UGA in its open reading frame reinterprets this triplet, programs SeC incorporation, and produces a selenoprotein (30), it was not surprisingly to find that fusion of an exogenous SECIS to the BAT SeD2 cDNA produced an artificial construct that yielded a functional deiodinase when transfected into COS cells (27) . Northern analysis showed that the putative mammalian SeD2 was encoded by a 7.5-kb transcript that was abundant in the BAT, pituitary, and brain of rats. In humans, the SeD2 messenger RNA (mRNA) is also found in placenta, skeletal muscle, skin, and thyroid (27, 31) , organs that show little, if any, D2 activity in other mammals; only human placental membranes contain a putative D2-like deiodinase (32) . To date, the mammalian homolog of SeD2 remains a virtual enzyme, because expression of the native SeD2 polypeptide has not been identified, and the required SeD2 SECIS has not been found.
To determine whether the native homolog of virtual SeD2 was the missing subunit of the 200-kDa brain D2, we set out to identify the native SeD2 protein in cultured astrocytes, BAT, and brain. In this report we show that this virtual 30-kDa selenoprotein is not expressed in mammals and is unrelated to native D2 activity, and that the native 7.5-kb SeD2 transcript codes for a 15-kDa protein lacking both deiodinating activity and SeC residue(s) in mammals.
Materials and Methods Materials
All reagents were of the highest purity commercially available. The approximately 1.5-kb BAT SeD2 cDNA was provided by Dr. St. Germain. Restriction endonucleases and DNA-and RNA-modifying enzymes were purchased from New England Biolabs, Inc. (Beverly, MA). The fmol sequencing kit was purchased from Promega Corp. 3 was prepared by radioiodination of BrAcT 3 and 3,3Ј-diiodothyronine, respectively, using methods described previously (33) . DMEM, antibiotics, Hanks' Balanced Salt Solution, glucose, and trypsin were obtained from Life Technologies; supplemented bovine calf serum was obtained from HyClone Laboratories, Inc. (Boulder, CO; selenium content, 42 ng/ml); (Bu) 2 cAMP and hydrocortisone were purchased from Sigma Chemical Co. (St. Louis, MO). All iodothyronines were of the l-configuration and were purchased from Henning Berlin GmbH & Co.
Culture conditions
Rat type I astrocyte cultures were prepared by enzymatic dispersion of neonatal rat brains as described previously (34) . Cells were grown in a humidified atmosphere of 5% CO 2 and 95% air at 37 C in complete growth medium, composed of DMEM supplemented with 15 mm sodium bicarbonate, 33 mm glucose, 1 mm sodium pyruvate, and 15 mm HEPES, pH 7.4 (supplemented DMEM), and containing 10% calf serum, 50 U/ml penicillin, and 90 g/ml streptomycin. The culture medium was changed twice weekly, and the cells were subcultured (ϳ3 ϫ 10 4 cells/cm 2 ) when they reached confluence (ϳ5-7 days). Confluent cell monolayers between passages 1-4 were used and contained more than 95% astrocytes, as determined by staining for the astrocyte-specific protein, glial fibrillary acidic protein. Unless otherwise noted, maximal D2 activity was induced in confluent monolayers of astrocytes by growth in serum-free medium for 24 h, followed by an additional 16 h in serum-free medium containing 1 mm (Bu) 2 cAMP and 100 nm hydrocortisone.
Rat C6 astrocytoma cells were obtained from the American Tissue Culture Collection (Manassas, VA) and grown in supplemented DMEM containing 10% calf serum and antibiotics.
Functional SeD2 constructs
The 5Ј-overhangs of an approximately 1-kb BamHI-XhoI restriction fragment containing the coding region of SeD2 were filled in using the Klenow fragment of DNA PolI, and the blunt-ended SeD2 was ligated into the EcoRV site of pcDNA3. The eukaryotic expression plasmid (pOPAL) was completed by inserting the AvrII-XbaI restriction fragment of the GPX1 gene containing the SECIS (nucleotides 902-1132) into the XbaI site of the pcDNA3-SeD2 construct. SeD2 orientation and construct integrity were confirmed by DNA sequencing.
Production of SeD2 cells
C6 astrocytoma cells (ϳ200,000 cells/25-cm 2 flasks) were transfected with 5 g pOPAL-SeD2 construct using DOTAP (Promega Corp., Madison, Wi) according to the manufacturer's instructions. After 24 h, the growth medium was supplemented with 200 g/ml G418 (Life Technologies), and the cells were grown until individual G418-resistant clonal growth was visible, usually within 2-3 weeks. Individual colonies of G418-resistant cells were isolated by limiting dilution in the presence of 200 g/ml G418, and the SeD2 cells used were chosen based on functional SeD2 expression. SeD2 cells were maintained in G418-supplemented medium to prevent loss of the SeD2 phenotype.
RNA isolation and Northern analysis
RNA was prepared from cell pellets by the method of Chomczynski and Sacchi (35) . Polyadenylated RNA was isolated by two cycles of chromatography over oligo(deoxythymidine)-cellulose (Stratagene, La Jolla, CA). RNA was separated on 1.2% agarose-formaldehyde gels and transferred to nitrocellulose (Duralose, Stratagene, La Jolla, CA) by diffusion blotting. Hybridization probes were prepared by random primer labeling (Promega Corp.), and blots were probed at 42 C for 16 h with 10 ng/ml 32 P-labeled SeD2 cDNA (nucleotides 1-1368) and 10 ng/ml 32 P-labeled human glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA control (CLONTECH Laboratories, Inc., Palo Alto, CA) in a solution composed of 50% formamide (vol/vol), 1 m NaCl, 10 mg/ml SDS, 0.1 g/ml dextran sulfate, and 100 g/ml salmon sperm DNA. All blots were washed to high stringency (30 mm NaCl, 3 mm sodium citrate, and 1 mg/ml SDS) at 65 C for 15 min. Hybridization signals were visualized and quantified by PhosphorImager analysis using ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA). RNA loading differences were normalized using the hybridization signals simultaneously generated with the control G3PDH probe.
Anti-SeD2 antibodies
Antibodies were raised in rabbits against synthetic peptides corresponding to the C-terminus of full-length (anti-SeD2-long) and truncated (anti-SeD2-short) SeD2. Two synthetic peptides to the full-length SeD2 protein were prepared: one corresponding to amino acids 247-266 [NH 2 -YNLQEVRSWLEKNFSKRCILD-COOH, SeD2(266)] contained a conservative substitution of a Cys for SeC at position 263 and one corresponding to amino acids 247-262 lacking the terminal four amino acid residues (-CILD-COOH) of SeD2(263). One synthetic peptide corresponding to the C-terminus of the truncated, 15-kDa polypeptide programmed when the first UGA codon of SeD2 mRNA signals translational arrest, amino acids 115-129 [NH 2 -YASAERPLVVNFGSAT-COOH, SeD-(2-129)], was also synthesized. All peptides contained an N-terminal tyrosine to facilitate diaminobenzidine coupling to keyhole limpet hemocyanin and for radioiodination.
Domain-specific SeD2 antibodies were purified by affinity chromatography before use on peptide-Affigel 10 (Bio-Rad Laboratories, Inc., Hercules, CA) affinity matrices. Primary antiserum was adsorbed to the cognate peptide-Affigel 10 matrix at 25 C, and unbound proteins were removed by repeated washes with 150 mm NaCl and 20 mm sodium phosphate buffer (pH 7.4; PBS). The bound, peptide-specific antibodies were eluted with 100 mm acetic acid and monitored by absorbance at 280 nm. Fractions containing antibody were neutralized by adding 0.1 vol 1 m Tris buffer (pH 8.6), pooled, and stored frozen at Ϫ70 C until use.
Immunocytochemistry
Cells were seeded onto glass coverslips (22 ϫ 22 mm) coated with poly-d-lysine (10 g/ml) and grown for 1-4 days as indicated in individual experiments. (Bu) 2 cAMP-stimulated astrocytes were treated with 10 mm colchicine for 60 min to relax the cell border before fixation; SeD2 cells were fixed directly. All cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 (vol/vol) in PBS. SeD2-related proteins were identified by incubation with affinity-purified, domain-specific anti-SeD2 IgG (0.1-1 g/ml) for 2 h at 4 C. Where indicated, peptide-blocked IgG was prepared by preincubation of the anti-SeD2 IgG with a 100-fold molar excess of cognate peptide for 60 min at room temperature before incubation with the fixed cells. Immune complexes were identified with Texas Red-conjugated, antirabbit IgG, and the coverslips were mounted and examined with epifluorescence illumination using a Zeiss Axioskop microscope (Carl Zeiss, New York, NY) equipped with an Olympus Corp. OM4 camera (New Hyde Park, NY). The micrographs shown are representative of 30 -40 independent fields.
Antisense deoxyoligonucleotide effects on D2 activity in SeD2 and stimulated glial cells
SeD2 and astrocytes were seeded at 5 ϫ 10 4 cells/well in six-well cluster plates and grown in complete growth medium for 24 h before the experiment. Increasing concentrations of a 24-mer thiophosphinate ester oligonucleotide complementary to the Kozak start site of SeD2 (5Ј-CTGAGGAGTCCCATGTTCTTTACC-3Ј, SeD2 antisense) were added to the growth medium, and the cells were grown for an additional 72 h. During the final 24-h period, D2 activity was induced in the euthyroid glial cell by the addition of 1 mm (Bu) 2 cAMP and 100 nm hydrocortisone. Cells were then washed free of the treatment medium, scraped from the plate, and collected by centrifugation. D2 activity was determined as detailed below; protein disulfide isomerase (PDI) expression was determined by Western blot analysis.
Hybrid selection of SeD2-encoding mRNA
Hybrid selection of SeD2-encoding mRNAs was performed using established procedures (36) . The prBAT 1-1 plasmid was denatured, filtered through 0.45-mm pore size nitrocellulose (ϳ10 g plasmid/ cm
2 ), and immobilized by UV cross-linking. Approximately 50 g heatdenatured, polyadenylated RNA from approximately 5 ϫ 10 8 cells of each cell type were hybridized to the nitrocellulose-immobilized SeD2 cDNA for 2 h at 50 C in a hybridization solution composed of 65% formamide (vol/vol), 400 mm NaCl, 0.2% (wt/vol) SDS, 30 mm 1,4-piperazine-diethanesulfonic acid buffer (pH 6.5), and 50 g/ml yeast transfer RNA. Unbound mRNA was eluted from the nitrocellulose filters by repeated washes at 65 C with 150 mm NaCl, 10 mm Tris buffer (pH 7.6), and 1 mm EDTA, and the specifically absorbed mRNA was eluted with diethylpyrocarbonate-treated H 2 O containing 75 g/ml yeast transfer RNA. Eluted mRNAs were extracted once with phenol-chloroform-isoamyl alcohol (50:48:2, vol/vol/vol), precipitated by ethanol, resuspended in diethylpyrocarbonate-treated H 2 O, and stored at Ϫ70 C until use.
Xenopus laevis oocyte expression of functional SeD2
Stage 5-6 X. laevis oocytes were defolliculated and microinjected by established procedures (14) with 2-5 ng hybrid selected mRNA from C6-, SeD2-, and cAMP-stimulated astrocytes. After injection, oocytes were incubated for 4 -5 days in modified Barth's medium. Pools of two oocytes were lysed in 100 l 10 mm HEPES (pH 7.0), 1 mm EDTA, and 10 mm dithiothreitol and used for enzyme analysis.
Analytical procedures
D2 activity was determined in cell lysates by measuring the release of radioiodide from 2 nm [
125 I]rT 3 (5 ϫ 10 5 cpm/pmol), unless otherwise indicated, at 20 mm dithiothreitol and 1 mm PTU in a total volume of 100 l. Deiodination reactions were performed in triplicate in 100 mm potassium phosphate buffer (pH 7.0) and 1 mm EDTA with 50 -100 g cell protein and incubated at 37 C for 60 -120 min. Product formation was measured as described previously (5), and the data are expressed as units per mg protein, where 1 U ϭ 1 fmol I Ϫ released/h. All experiments were performed at least three times, and statistical analysis was performed using Student's t test.
Results
The hormone-dependent, differential expression of D2 activity in astrocytes allowed the relationship between enzyme activity and SeD2 mRNA levels to be examined. Shown in Fig. 1 are the SeD2 mRNA levels (A) and the D2 activity (B) in astrocytes treated with (Bu) 2 cAMP in the absence or presence of hydrocortisone. Unstimulated hypothyroid astrocytes lacked both D2 activity and the SeD2 transcript, whereas hydrocortisone treatment induced the 7.5-kb SeD2 mRNA without a corresponding appearance of D2 activity. (Bu) 2 cAMP treatment induced both SeD2 mRNA and D2 activity, and maximal expression of both SeD2 mRNA and D2 activity was observed in hypothyroid astrocytes treated with both (Bu) 2 cAMP and hydrocortisone. In euthyroid astrocytes, the abundance of SeD2 mRNA reached levels identical to those in the hypothyroid astrocytes, but D2 activity reached only 20% of that in the hypothyroid cells.
Because the SeD2 mRNA was very abundant in (Bu) 2 cAMP-stimulated astrocytes, we used these cells for identification and characterization of the native SeD2 polypeptide. Two anti-SeD2 antibodies were prepared; antiSeD2-long was raised against the C-terminus of the deduced amino acid sequence of the full-length (30-kDa) SeD2, and anti-SeD2-short was raised against the catalytic core of SeD2, assuming that the first UGA codon terminates translation. As shown in Fig. 2 , anti-SeD2-long specifically recognized an epitope(s) in the C-terminus of SeD2 that is upstream of the last four deduced amino acids SeD2(266) and SeD2(263), but did not recognize peptides derived from the C-termini of rat D1, rat D3, or the p29 subunit of D2. Anti-SeD2-short (Fig. 2B ) recognized only its cognate peptide.
Evaluation of native SeD2 expression by antiSeD2 antibodies
To produce an unambiguous source of a functional mammalian SeD2, rat C6 astrocytoma cells (C6) were transfected with a chimera constructed of the coding region of BAT SeD2 cDNA and the SECIS from human GPx carried in pcDNA3. Cells constitutively expressing this SeD2 chimera were selected by G418 resistance (SeD2 cells) and contained from 100 -300 U heterologous D2 activity/mg cell protein. Control C6 cells lacked D2 activity.
We first examined the ability of the C-terminus-specific, anti-SeD2 antibody (SeD2-long) to immunoprecipitate catalytically active D2 using detergent extracts of microsomes isolated from hypothyroid rat BAT and cerebral cortex and detergent extracts of SeD2 cells and stimulated astrocytes. D2-containing detergent extracts (BAT, 68 Ϯ 7 U/mg protein; cerebral cortex, 37 Ϯ 3 U/mg protein; SeD2 cells, 49 Ϯ 5 U/mg protein; (Bu) 2 cAMP-stimulated astrocytes, 89 Ϯ 10 U/mg protein; n ϭ 3) were incubated with anti-SeD2-long antiserum (1:100 final dilution) in the absence or presence of a 100-fold molar excess of blocking peptide. The immune complexes were then removed using protein A-Sepharose, and the unbound D2 activity remaining in the clarified supernatant was determined. As shown in Fig. 3 , the antiSeD2-long antiserum selectively immunoprecipitated 60% of D2 activity solubilized from SeD2 cells, but failed to precipitate D2 activity in detergent extracts from (Bu) 2 cAMP-stimulated rat BAT or cerebral cortex. These data show that the anti-SeD2 long recognizes the heterologous SeD2 translation product, but does not recognize the native D2 in astrocytes or other rat tissues.
The failure of SeD2-long to recognize the native D2 indicates that the C-terminus of the native enzyme differs from that of the deduced amino acid sequence. As the cryptic catalytic core epitope(s) of SeD2 is the hallmark of the selenodeiodinase family, we used the SeD2-short antiserum for Western analysis. Shown in Fig. 4 are immunoblots of the SeD2-related proteins in the C6 null cell, the SeD2 cell, and unstimulated and (Bu) 2 cAMP-stimulated astrocytes. Compared with the C6 null cell, which lacked D2 activity, SeD2 cell lysates (390 U/mg protein; D2) contained two new immunoreactive bands with M r of about 30 and 15 kDa, and both bands were specifically blocked by excess peptide, indicating that both the full-length (30 kDa) and the truncated (15 kDa) SeD2 proteins were present in the transfected SeD2 cells. In contrast to the SeD2 cell, (Bu) 2 cAMP-stimulated astrocytes (Fig. 4B ) expressing approximately 10-fold greater levels of D2 activity (2960 U/mg protein) and maximal levels of SeD2 mRNA contained only the 15-kDa immunoreactive protein, indicating that the first UGA of the SeD2 mRNA terminated translation. No peptide-blocked 30-kDa protein was observed in (Bu) 2 cAMP-stimulated astrocytes. Both unstimulated astrocytes and C6 null cells lacked any specific 30-or 15-kDa immunoreactive signal. Thus, the anti-SeD2-short antibody recognizes both full-length (30-kDa) and truncated (15-kDa) SeD2 translation products on immunoblots.
Although the abundance of the full-length (30-kDa) SeD2 protein in the transfected SeD2 cells suggests an efficient read-through of the first UGA codon of the chimeric transcript, it does not show that a SeC residue was incorporated into the polypeptide chain. In fact, the modest effects of Se deprivation on steady state D2 activity (12) may be due to the presence of ubiquitous opal suppressor transfer RNAs (37, 38) that reinterpret UGA codons and would produce a fulllength SeD2 protein lacking SeC. To examine this possibility, we depleted SeD2 cells of Se and compared the effects of Se depletion on the expression of SeD2 activity. As shown in Fig.  5 , the SeD2 activity was decreased by about 80% after 3 days of selenium deficiency. These data confirm that SeC is incorporated at the first UGA codon in transcripts derived from the SeD2:SECIS cDNA chimera and that read-through is dependent on Se in SeD2 cells.
Immunocytochemistry of SeD2 expression in cells and rat tissues
We next used anti-SeD2-long and anti-SeD2-short antibodies to determine the abundance of these SeD2-related proteins in cells and tissues expressing D2 activity. Shown in Fig. 6 are representative photomicrographs of SeD2 cells, hypothyroid BAT, hypothyroid cerebral cortex, and cAMPstimulated astrocytes stained for full-length (30-kDa) SeD2 with anti-SeD2-long IgG. Abundant, peptide-blocked immunostaining was observed in the transfected SeD2 cells, consistent with the ability of anti-SeD2 long to immunoprecipitate deiodinase activity. In contrast, no specific staining was observed in (Bu) 2 cAMP-stimulated astrocytes, hypothyroid BAT, or hypothyroid cerebral cortex. In control studies, the p29 subunit of D2 was detected in all cells and tissues containing D2 activity, such as brain, BAT, and stimulated astrocytes, but not in the SeD2 cells expressing the virtual SeD2 protein (Fig. 6) . Although no immunoreactive full-length (30-kDa) SeD2 protein was found in rat tissues, all cells and tissues expressing the native SeD2 mRNA showed abundant immunoreactive, peptide-blocked signals that were uniformly distributed throughout the cell when the 15-kDa SeD2 translation product was visualized with anti-SeD2-short antiserum (Fig. 7) . These data show that a full-length (30-kDa) native SeD2 protein is not translated from the 7.5-kb SeD2 mRNA in rat cells and organs, whereas the truncated 15-kDa product is readily observed. Thus, the native SeD2 transcript programs the translation of a catalytically inactive protein in rat tissues.
FIG. 3.
Immunoprecipitation of D2 activity from cAMP-stimulated glial cells, BAT, cerebrocortical microsomes, and SeD2 cells. Detergent lysates were prepared in 10 mM HEPES (pH 7), 1 mM EDTA, and 10 mM n-octyl glucoside and were clarified by centrifugation (250,000 ϫ g for 30 min). Clarified extracts were incubated, in triplicate, in a total volume of 100 l with anti-SeD2-long antisera (1:100 dilution) and 10 l protein A-Sepharose beads with or without a 100-fold molar excess of blocking peptide for 90 min at 4 C. Immune complexes bound to protein A-Sepharose were removed by centrifugation, and D2 activity remaining in the clarified supernatant was determined as described in Materials and Methods.
Analysis of native SeD2 mRNA
Two additional experimental approaches were used to examine directly the ability of native SeD2 mRNA to program the synthesis of functional D2 in astrocytes. The first used a 24-mer SeD2 antisense oligonucleotide to selectively decrease the levels of the SeD2 mRNA, followed by D2 activity determination. Cells were incubated for 72 h with increasing concentrations of SeD2 antisense or with a control PDI antisense, and D2 activity was determined in cell lysates. To ensure comparable levels of D2 activity, euthyroid glial cells were used in this study. In all cells, the D2 activity found in cells incubated with the control PDI antisense oligonucleotide was used to control for nonspecific effects of RNA: DNA dimerization in the cytoplasm. Treatment with PDI antisense for 3 days decreased the cellular content of this 55-kDa protein by more than 75% in all cells examined (data not shown), indicating that the uptake of nuclease-resistant oligonucleotides was similar in the two cell types examined. In addition, we previously found that any deoxyoligonucleotide would decrease cAMP-induced D2 activity by 30 -40%, 1 and in this study the D2 activity in the PDI antisense-treated, (Bu) 2 cAMP-stimulated, euthyroid treated astrocytes fell by about 35% (175 Ϯ 20 U/mg protein vs. 115 Ϯ 12 U/mg protein, with or without 10 m PDI antisense, respectively), indicating that native D2 mRNA levels in the stimulated astrocyte were rate limiting for enzyme expression. As shown in Fig. 8 , addition of increasing concentrations of SeD2 antisense led to a progressive loss of D2 activity in SeD2 cells compared with the D2 activity in cells treated with the control antisense oligonucleotides for an unrelated protein (PDI). In contrast, the D2 activity in euthyroid, (Bu) 2 cAMP-stimulated astrocytes was unaffected by the SeD2 antisense oligonucleotide, indicating that enzyme activity in astrocytes does not depend on any translation product encoded by the SeD2 mRNA.
Finally, we examined whether the native SeD2 mRNA would program the synthesis of a functional D2 in the oocyte expression system after enriching the native SeD2 mRNA by hybrid selection. Hybrid-selected, chimeric SeD2 transcripts from SeD2 cells served as the positive control, whereas the nonspecifically enriched mRNA from catalytically inactive C6 cells served as the negative control. Northern analysis of the hybrid selected mRNA from (Bu) 2 cAMP-stimulated astrocytes showed the expected enrichment of the approximately 7.5-kb mRNA (Fig. 9B, inset) confirming that an intact SeD2 mRNA was isolated by this enrichment strategy. As 1 Safran, M., and J. Leonard, unpublished observation.
FIG. 4.
Western blot analysis of SeD2 protein(s) in unstimulated, (Bu) 2 cAMP-stimulated glial cells, C6 cells, and SeD2 cells. Cells were scraped from the dish and collected by centrifugation, and cell lysates were prepared in 10 mM HEPES (pH 7) and 1 mM EDTA. Cell proteins (50 g) were separated on 15% SDS-PAGE gels, electroblotted onto nitrocellulose, and probed with a 1:1000 dilution (final) of anti-SeD2-short antiserum with or without 10 g/ml blocking peptide. Immune complexes were identified with goat antirabbit alkaline phosphatase conjugate and 5-bromo-4-chloro-3-indolyl-phosphate (A) or goat antirabbit horseradish peroxidase conjugate and chemiluminescent detection (B). Immune complexes were imaged by laser scanning densitometry or PhosphorImager analysis.
FIG. 5. Selenium-dependent expression of SeD2 activity in SeD2 cells. SeD2 cells were grown in chemically defined medium in the absence or presence of 40 nM Se for 3 days. Cells were scraped from the dish and collected by centrifugation, and cell lysates were prepared by sonication and D2 activity determined as described in Materials and Methods. Data are reported as the mean Ϯ SE (n ϭ 5).
shown in Fig. 9A , the hybrid-selected SeD2 transcripts from SeD2 cells and (Bu) 2 cAMP-stimulated astrocytes programmed the synthesis of the expected immunoreactive, 15-kDa SeD2 protein in reticulocyte lysates, illustrating that the enriched SeD2 mRNAs was intact and functional. As reticulocyte lysates cannot incorporate SeC into the elongating polypeptide chain, only the 15-kDa translation product from the enriched SeD2 transcripts was expected. As shown in Fig.  9B , oocytes injected with hybrid-selected, artificial SeD2 mRNA isolated from SeD2 cells programmed the synthesis of functional D2 activity, whereas the enriched SeD2 mRNA from (Bu) 2 cAMP-stimulated astrocytes produced no D2 activity. RNA from control C6 cells also yielded no D2 activity. These data show that SeD2 transcripts containing a heterologous SECIS encode a functional D2, whereas the native 7.5-kb SeD2 mRNA programs the synthesis of the N-terminal 15 kDa of SeD2, but not a full-length, catalytically active enzyme, suggesting that the native transcript lack the required SECIS.
Discussion
The search for D2 has been driven in large part by the key role this enzyme plays in T 3 homeostasis in the brain. The data in this report show that the 7.5-kb SeD2 mRNA does not encode the catalytically active D2 enzyme in rats, but, rather, programs the synthesis of a catalytically inactive 15-kDa protein of unknown function. This is consistent with the functional analysis performed on the original rBAT1-1 cDNA clone (SeD2), which lacks the SECIS necessary to synthesize a selenoprotein (27) . Thus, the deiodinating activity produced in vitro after appending an exogenous SECIS to the 3ЈUTR of SeD2 cDNA appears to be an artifact resulting from the similarity between the rBAT 1-1 clone and the amphibian SeD2 gene product and from the ability of a SECIS element to direct SeC incorporation at any UGA codon(s) (30, 39) .
The abundant D2 activity produced in stimulated astrocytes was exploited in the search for the native SeD2 translation product. Despite a rough correlation between the expression of the 7.5-kb SeD2 transcript and D2 activity, Western blot, immunoprecipitation, and immunohistochemistry failed to find any immunoreactive 30-kDa SeD2 protein FIG. 6 . Immunocytochemistry of full-length (30-kDa) SeD2 and the p29 subunit of D2 proteins in SeD2 cells, hypothyroid BAT, cerebral cortex, and stimulated glial cells. Cells and tissues were fixed and permeabilized, and the full-length (30-kDa) SeD2 protein was identified with 1 g/ml affinity-purified, anti-SeD2-long IgG. The p29 subunit of D2 was identified with a 1:1000 dilution of anti-P29 antiserum (23) . Immune complexes were visualized using a goat antirabbit IgG:Texas Red conjugate.
FIG. 7.
Immunocytochemistry of the truncated (15-kDa) SeD2 protein in hypothyroid BAT, stimulated glial cells, SeD2 cells, and hypothyroid cerebral cortex. Cells and tissues were fixed and permeabilized, and the truncated SeD2 (15 kDa) protein was identified with 10 g/ml of affinity-purified, anti-SeD2-short IgG in the absence or presence of 50 g/ml blocking peptide. Immune complexes were visualized using a goat antirabbit IgG:Texas Red conjugate.
in mammalian tissues. In contrast, the 15-kDa translation product encoded by the first 390 nucleotides of the open reading frame of the native SeD2 transcript was readily expressed. On the other hand, the catalytically active, virtual SeD2 was readily immunoprecipitated from cells transfected with the SeD2-SECIS chimera, but native D2 activity was unaffected. Direct analysis of translation products programmed by native SeD2 mRNA in situ using antisense oligonucleotides or in vitro using oocytes injected with hybrid selected SeD2 mRNA also failed to identify any native functional SeD2. Taken together, these data show that the catalytically active D2 found in mammalian tissues is not encoded by the native 7.5-kb SeD2 transcript, as the mature mRNA appears to lack the SECIS required to incorporate the SeC residue essential for full-length translation of this gene product.
The relative abundance of the 7.5-kb SeD2 transcript in the stimulated astrocyte was unexpected and was 35% of that for the glycolytic enzyme, G3PDH, indicating that this putative SeD2 transcript is not a rare message. In fact, relative to G3PDH mRNA, the quantity of the 7.5-kb SeD2 transcript is about 5-fold greater than that of the D1 mRNA in PK1 cells that express approximately 10,000-fold more deiodinating activity that astrocytes. The unexpected abundance of this mRNA suggests that the transcript either codes for another gene product, presumably the catalytically inactive 15-kDa protein, or is a remnant of ontogeny.
The large size of the SeD2 mRNA relative to that of other members of the mammalian selenodeiodinase family, is also an unusual feature of this transcript. From fish to man the mRNAs encoding D1 and D3 range in size from about 1.5-2.4 kb (13, 15, 17, 26, 40) . Similarly, the full-length SeD2 transcript in Rana catesbeiana is only 1.5 kb in length (26) . As the SECIS element in all known selenoproteins is located no more than 1.5 kb downstream from the UGA triplet, St. Germain and co-workers assumed that this essential element was located in the approximately 5 kb of the 3ЈUTR presumably lost during the cloning of rBAT 1-1 and its human homolog, even though both clones were polyadenylated (27) , and a naturally occurring polyadenylation signal variant, AAUACA (41) , is located 13 bases upstream from the polyadenylase tail present in the rBAT 1-1 clone. Recently, Toyoda and colleagues 2 cloned an approximately 5.1-kb SeD2 cDNA (accession no. AB011068) from a rat brain cDNA library, adding more than 4 kb of 3ЈUTR to the sequence provided by rBAT 1-1. A complete search of the new 3ЈUTR failed to identify any SECIS element(s), indicating that this essential element, if present, would be located more than 5 kb downstream of the UGA codon, where it would function poorly, if at all. However, direct experimental analysis of the translation products encoded by the native 7.5-kb SeD2 mRNA clearly indicates that the mature transcript lacks a functional SECIS element.
Alternative splicing has also been proposed to lead to the loss of the 3ЈUTR and the presumed SECIS, from rBAT 1-1. Although only a single SeD2 transcript was observed in astrocytes, there is one putative splice site in the open reading frame of SeD2 (starting at nucleotide 1095) that could exchange the C-terminal 85 amino acids of the mammalian processed transcript. However, this hypothesis is very unlikely, because the C-terminus of the SeD2 protein shares more than 80% amino acid identity from amphibian to man. Although it seems likely that both alternate splicing and/or gene rearrangement of the primordial SeD2 transcript led to the large increase in the size of the mature transcript in mammals, this also eliminated the essential SECIS and disabled this potential selenodeiodinase transcript. Thus, the mammalian SeD2 transcript belongs to the pool of primordial gene products that have undergone repeated recombination and whose original translation product(s) has been altered. The only translation product of the native 7.5-kb SeD2 transcript found in rats is the 15-kDa truncated protein.
Unlike the mammalian virtual SeD2, the amphibian SeD2 fulfills all of the criteria for an authentic selenodeiodinase. The full-length cDNA contains the UGA triplet in the open reading frame and has the required SECIS in the 3ЈUTR of the transcript (26) , and expression studies using unadulterated cDNA produced a deiodinase with the catalytic properties of the native frog enzyme. As frogs lack a PTU-sensitive D1, they rely on SeD2 to produce T 3 at critical times during metamorphosis. Thus, the amphibian SeD2 most likely represents one of the earliest known members of the selenodeiodinase family with at least some of the characteristics of all of the mammalian deiodinase isozymes.
Many of the problems surrounding deiodinase isozyme identification have occurred (42) (43) (44) because the properties of these enzymes in most lower vertebrates deviate from the classical operational definitions of the mammalian isozymes. For example, neither the frog SeD2 nor a D1 variant in the fish kidney is inhibited by the classical D1 inhibitors, PTU, or thiogold glucose (40) . Cloning of Tilapia kidney enzyme (TN-12) revealed that it was a true selenodeiodinase containing both a UGA triplet in the open reading frame and two SECIS elements in the 3ЈUTR (40) , and the coding region of this cDNA shared approximately 50% identity with mammalian D1 (40) . As the lack of PTU inhibition is a hallmark of the mammalian D2 enzyme (1-3) , by functional analysis alone both the fish kidney and the amphibian skin D2 would have been mistakenly classified as D2 isozymes. In fact, closer analysis of the amphibian SeD2 reveals that the frog enzyme is inhibited by PTU, albeit at 10-to 50-fold higher concentrations than those required to inhibit D1 (28) . Thus, it appears that the deiodinase(s) found in lower vertebrates represents intermediate forms in the evolving selenodeiodinase family and that PTU inhibition is a poor discriminator between isozymes when evaluating nonmammalian deiodinases.
The influence of selenium on the expression of D2 catalytic activity has recently been revisited by Courtin and co-workers (45) . They found that at early times after cAMP-dependent induction, D2 activity was temporally correlated with the appearance of the 7.5-kb SeD2 mRNA and that about 50% of the T 4 -deiodinating activity in acutely stimulated (6-h) primary brain cell cultures was lost after prolonged withdrawal of selenium. In light of our findings that the presumed SeD2 mRNA is unrelated to D2 activity in astrocytes and encodes a 15-kDa catalytically inactive polypeptide, the effects of selenium on T 4 deiodination are probably related to the presence of the selenium-dependent D1 and D3 enzymes in primary brain cell cultures employed by these workers (34, 46) and by the absence of the D1 inhibitor, PTU, from their T 4 deiodination assay. Alternatively, prolonged selenium deprivation may render the cell more susceptible to oxidative stress, and this would be especially damaging to enzymes found in the plasma membrane, such as D2, although we were unable to observe any effect on cAMPinduced, steady state, D2 activity after 5 days of selenium deprivation (12) .
Although the identity of the remaining subunits of mammalian D2 is unknown, clearly SeD2 is not a component of the functional enzyme in vivo, and the p29 substrate-binding D2 subunit remains the only known subunit.
